| # | Drug | Count |
|---|---|---|
| 0 | EFGARTIGIMOD ALFA | 36 |
| 1 | ECULIZUMAB | 14 |
| 2 | PREDNISONE | 12 |
| 3 | PYRIDOSTIGMINE BROMIDE | 9 |
| 4 | AZATHIOPRINE | 8 |
| 5 | PYRIDOSTIGMINE BROMIDE ORAL | 6 |
| 6 | MYCOPHENOLATE MOFETIL | 5 |
| 7 | PREDNISOLONE | 5 |
| 8 | PREDNISOLONE ORAL | 5 |
| 9 | PREDNISOLONE ORAL SOLUTION | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EFGARTIGIMOD ALFA | 36 | 0.0091 |
| 1 | NIPOCALIMAB-AAHU | 2 | 0.0063 |
| 2 | EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) | 1 | 0.0021 |
| 3 | PYRIDOSTIGMINE BROMIDE ORAL | 6 | 0.0017 |
| 4 | MEBENDAZOLE | 1 | 0.0013 |
| 5 | PYRIDOSTIGMINE BROMIDE | 9 | 0.0012 |
| 6 | GLYCOPYRRONIUM | 1 | 0.0006 |
| 7 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| 8 | OXYTOCIN | 1 | 0.0003 |
| 9 | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL AND FERROUS FUMARATE | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Neonatal Fc Receptor Blocker [EPC] | 41 |
| 1 | Corticosteroid [EPC] | 18 |
| 2 | Complement Inhibitor [EPC] | 15 |
| 3 | Purine Antimetabolite [EPC] | 8 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 5 |
| 5 | Nitroimidazole Antimicrobial [EPC] | 3 |
| 6 | Proton Pump Inhibitor [EPC] | 3 |
| 7 | Vitamin C [EPC] | 3 |
| 8 | Vitamin D [EPC] | 3 |
| 9 | Calcineurin Inhibitor Immunosuppressant [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Neonatal Fc Receptor Blocker [EPC] | 41 | 0.0093 |
| 1 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 2 | Anthelmintic [EPC] | 1 | 0.0003 |
| 3 | Oxytocic [EPC] | 1 | 0.0003 |
| 4 | Complement Inhibitor [EPC] | 15 | 0.0003 |
| 5 | Human C1 Esterase Inhibitor [EPC] | 1 | 0.0003 |
| 6 | Antiparasitic [EPC] | 1 | 0.0002 |
| 7 | Pediculicide [EPC] | 1 | 0.0002 |
| 8 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 9 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |